Search Results - "Jang, M.K."

Refine Results
  1. 1

    Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B by Shin, W.G, Park, S.H, Jang, M.K, Hahn, T.H, Kim, J.B, Lee, M.S, Kim, D.J, Jun, S.-Y, Park, C.K

    Published in Digestive and liver disease (01-04-2008)
    “…Abstract Background There have been still few valuable markers that can be used as indirect markers of liver fibrosis in chronic hepatitis B. Aims This study…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Synthesis and Characterization of Polythiophene and Poly (3-methylthiophene) Nanotubes and Nanowires by Park, D.H., Kim, B.H., Jang, M.K., Bae, K.Y., Lee, S.J., Joo, J.

    Published in Synthetic metals (21-09-2005)
    “…We synthesized nanotubes and nanowires of π-conjugated polythiophene (PT) and poly (3-methylthiophene) (P3MT) by using nanoporous anodic aluminum oxide (A1 2O…”
    Get full text
    Journal Article Conference Proceeding
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Comparative Performance Analysis of Donor-Derived Cell-Free DNA to Detect Acute Rejection in Single and Double Lung Transplant Recipients by Meda, R., Fu, S., Yu, K., Charya, A., Kong, H., Jang, M.K., Andargie, T., Park, W., Lee, J., Tunc, I., Berry, G.J., Marboe, C., Shah, P.D., Nathan, S.D., Keller, M.B., Agbor-Enoh, S.

    “…Plasma donor-derived cell-free DNA (ddcfDNA) is a sensitive biomarker for acute rejection (AR). However, its performance remains unknown for single (SL) vs…”
    Get full text
    Journal Article
  13. 13

    Circulating microRNA Biomarkers in Cellular and Antibody-Mediated Heart Transplant Rejection by Shah, P., Agbor-Enoh, S., Bagchi, P., deFilippi, C.R., Mercado, A., Diao, G., Morales, D.J., Shah, K.B., Najjar, S.S., Feller, E., Hsu, S., Rodrigo, M.E., Lewsey, S.C., Jang, M.K., Marboe, C., Berry, G.J., Khush, K.K., Valantine, H.A.

    “…Non-invasive monitoring of heart allograft health is an important clinical goal and circulating microRNAs (miRs) have been associated with acute rejection in…”
    Get full text
    Journal Article
  14. 14

    Cell-Free DNA to Distinguish High Risk Donor Specific Antibodies in Heart Transplantation by Bon, A.M., Gerhard, E.F., Mathew, J., Kong, H., Jang, M.K., Henry, L., Lee, B.S., Hsu, S., Shah, K., Tchoukina, I., Sterling, S., Rodrigo, M.E., Najjar, S., Marboe, C., Berry, G.J., Valantine, H.A., Shah, P., Agbor-Enoh, S.

    “…Donor specific antibodies (DSA) develop in a significant fraction of heart transplant recipients (HTR). Enhanced characterization of high-risk DSA may permit…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Early Donor-Derived Cell-Free DNA Predicts Peak Allograft Function in Heart Transplant by Brusca, S.B., Jang, M.K., Shah, P., Shah, K.B., Hsu, S., Feller, E.D., E, M., Najjar, S.S., Fideli, U.S., Kong, H., Marishta, A., Bhatti, K., Yang, Y., Tunc, I., Solomon, M.A., Berry, G., Marboe, C., Agbor-Enoh, S., Valantine, H.A.

    “…Donor-derived cell-free DNA (ddcfDNA) is a validated marker of allograft injury in heart transplant, predicting both acute cellular (ACR) and antibody mediated…”
    Get full text
    Journal Article
  17. 17

    Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation by Doshi, A.H., Tushak, Z., Kong, H., Garcia, V., Jang, M.K., Shah, P., Hsu, S., Feller, E.D., Rodrigo, M.E., Najjar, S.S., Fideli, U.S., Marishta, A., Bhatti, K., Yang, Y., Tunc, I., Solomon, M.A., Berry, G., Marboe, C., Agbor-Enoh, S., Shah, K.B., Valantine, H.A.

    “…African American (AA) patients are at risk for increased rates of rejection after heart transplantation (HT). We compared cell-free DNA (cf-DNA) levels after…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20